Clinical Trial

Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer

Name: Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer — clinical trial record (NCT07643012)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ADAPT-EC

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate the safety, tolerability, and preliminary efficacy of moderately hypofractionated (15-fraction) MR-guided adaptive pelvic IMRT in patients with endometrial cancer.

Trial Details

NCT Number	NCT07643012
Lead Sponsor	Rutgers, The State University of New Jersey
Conditions	Endometrial Cancer
Enrollment	30 participants
Start Date	2026-06
Primary Completion	2029-06 (estimated)
Study Completion	2029-06 (estimated)
Updated on ClinicalTrials.gov	2026-06-11